You are here: Industry Insights > CBD

News List

Can CBD Help Curb COVID? Maybe, But More Study Needed drugs.com
January 24, 2022
Cannabidiol, a compound derived from marijuana, appears to show promise in blocking replication...
CBD and Cannabis Products for Acne, Psoriasis? Buyer Beware, Dermatologists Say drugs.com
January 17, 2022
Growing numbers of folks are turning to CBD or cannabis products to treat skin conditions like acne or rosacea, but researchers warn that the science on their safety and power hasn't kept up with demand.
Catalent enters CBD anaesthetic product formulation project cphi-online
July 19, 2021
The company will use its orally disintegrating tablet technology Zydis for JOS Pharmaceuticals' licensed CBD product
CBD Products Gain Following Among Fibromyalgia Patients drugs
July 01, 2021
Could the answer to easing the tough-to-treat chronic pain and fatigue of fibromyalgia be found in edibles and other products containing CBD?
Cannabinoids: The Next Frontier for Cosmeceuticals? cphi-online
June 21, 2021
The market for CBD is growing and it is not just the pharmaceutical industry that is exploring its potential.
CBD tablet significantly improves diabetic peripheral neuropathic pain europeanpharmaceuticalreview
May 18, 2021
In a Phase II trial, a cannabidiol (CBD) sublingual tablet reduced pain scores in patients with diabetic peripheral neuropathy by approximately 50 percent.
FDA Warns Companies Illegally Selling Over-the-Counter CBD Products for Pain Relief americanpharmaceuticalreview
March 29, 2021
The U.S. Food and Drug Administration (FDA) has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).
FDA sends warning to companies selling unapproved CBD products europeanpharmaceuticalreview
March 25, 2021
The warning letters were issued to two companies illegally selling over-the-counter cannabidiol (CBD) products for pain relief.
SciSparc to Commence Pre-Clinical Study Using CBD-Based Treatment for Epilepsy americanpharmaceuticalreview
March 16, 2021
SciSparc has entered into an agreement with The Sheba Fund for Health Services and Research, to perform a pre-clinical study for the evaluation of the Company's SCI-210 drug development program, a proprietary novel pharmaceutical preparation ...
Report calls for development of new cannabis testing technologies europeanpharmaceuticalreview
July 15, 2020
According to research, the rise in demand for high-quality cannabis will also drive growth in the cannabis testing market, where new technologies are needed to overcome current limitations.

Previous page 1 2 3 Next page